Gelasia Tomentosa Butanolic Extract Exhibits Antiproliferative Activity Against MCF-7 Breast Cancer Cells: Mechanistic Insights into Synergistic EGFR and TOP2A Targeting

Objective: This preliminary study investigated the in vitro cytotoxicity and selectivity of the Gelasia tomentosa butanolic extract (Gt-BuOH) against MCF-7 breast cancer cells, using HFF fibroblasts as a non-malignant control, and explored associations between treatment and changes in p-EGFR, TOP2A, and TNF-α protein levels. Molecular docking was performed to generate hypotheses. Materials and Methods: Gt-BuOH (13.6% w/w fatty extract) was prepared by liquid-liquid partitioning of 650 g of powdered aerial parts. Chemical composition was characterized by GC-MS with retention index matching; compounds with similarity index ≥70% were tentatively identified. Cytotoxicity was determined using the MTT assay for cell viability at 0.1–1000 µg/mL in the MCF-7 cancer cell line and healthy HFF cells after 24 h and 72 h of incubation. Quantification of p-EGFR, TOP2A, and TNF-α was performed by ELISA. Key phytoconstituents were docked against these targets, with binding affinities estimated using AutoDock Vina. Results: Gt-BuOH inhibited MCF-7 cells in a concentration- and time-dependent manner (2.0 ± 0.2% to 75.0 ± 0.3% at 72 h; IC₅₀ = 431.8 µg/mL) with low toxicity towards HFF (IC₅₀ > 1000 µg/mL; selectivity index > 2.32). GC-MS identified methyl oleate (71.62% of total ion chromatogram area), propanoic anhydride, and methyl butyrate as the principal constituents; the profile is dominated by fatty-acid derivatives rather than phenolics. Gt-BuOH treatment was associated with reduced p-EGFR, TOP2A, and TNF-α levels in MCF-7 cells but not in HFF cells. Docking predicted weaker individual binding affinities for the three constituents than for reference inhibitors; no synergy or multi-target advantage is claimed. Conclusion: These preliminary findings support further investigation of Gt-BuOH as a source of fatty-acid-derived antiproliferative agents, but bioassay-guided fractionation, additional cell lines, and functional validation are required before any therapeutic claims can be made.

Authors

Institutions

Publication Details

Journal
Journal of cancer research updates
Published
2026-11-14
DOI
https://doi.org/10.30683/1929-2279.2026.15.35
Primary Topic
Phytochemical Studies and Bioactivities
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Gelasia Tomentosa Butanolic Extract Exhibits Antiproliferative Activity Against MCF-7 Breast Cancer Cells: Mechanistic Insights into Synergistic EGFR and TOP2A Targeting

Youssef Shakuri Yasin, Waleed Khalid Ahmed, S Shaker, Ali Mala Khedir Galalaey et al.
Journal of cancer research updates
Phytochemical Studies and Bioactivities
article

Gelasia Tomentosa Butanolic Extract Exhibits Antiproliferative Activity Against MCF-7 Breast Cancer Cells: Mechanistic Insights into Synergistic EGFR and TOP2A Targeting

Youssef Shakuri Yasin, Waleed Khalid Ahmed, S Shaker, Ali Mala Khedir Galalaey, Ahmed Mohsin Abdulkhadim, Amjed Abbawe Salih, Azal Hamoody Jumaa, Amenh Mohammed Abdulrahman
article en

Abstract

Objective: This preliminary study investigated the in vitro cytotoxicity and selectivity of the Gelasia tomentosa butanolic extract (Gt-BuOH) against MCF-7 breast cancer cells, using HFF fibroblasts as a non-malignant control, and explored associations between treatment and changes in p-EGFR, TOP2A, and TNF-α protein levels. Molecular docking was performed to generate hypotheses. Materials and Methods: Gt-BuOH (13.6% w/w fatty extract) was prepared by liquid-liquid partitioning of 650 g of powdered aerial parts. Chemical composition was characterized by GC-MS with retention index matching; compounds with similarity index ≥70% were tentatively identified. Cytotoxicity was determined using the MTT assay for cell viability at 0.1–1000 µg/mL in the MCF-7 cancer cell line and healthy HFF cells after 24 h and 72 h of incubation. Quantification of p-EGFR, TOP2A, and TNF-α was performed by ELISA. Key phytoconstituents were docked against these targets, with binding affinities estimated using AutoDock Vina. Results: Gt-BuOH inhibited MCF-7 cells in a concentration- and time-dependent manner (2.0 ± 0.2% to 75.0 ± 0.3% at 72 h; IC₅₀ = 431.8 µg/mL) with low toxicity towards HFF (IC₅₀ > 1000 µg/mL; selectivity index > 2.32). GC-MS identified methyl oleate (71.62% of total ion chromatogram area), propanoic anhydride, and methyl butyrate as the principal constituents; the profile is dominated by fatty-acid derivatives rather than phenolics. Gt-BuOH treatment was associated with reduced p-EGFR, TOP2A, and TNF-α levels in MCF-7 cells but not in HFF cells. Docking predicted weaker individual binding affinities for the three constituents than for reference inhibitors; no synergy or multi-target advantage is claimed. Conclusion: These preliminary findings support further investigation of Gt-BuOH as a source of fatty-acid-derived antiproliferative agents, but bioassay-guided fractionation, additional cell lines, and functional validation are required before any therapeutic claims can be made.

Journal of cancer research updatesVol. 15(4)
University of Kirkuk (IQ), University Of Fallujah (IQ), Iraqi University (IQ), Bilad Alrafidain University College (IQ), Salahaddin University-Erbil (IQ), University of Tikrit (IQ)
Phytochemical Studies and Bioactivities
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon